Degree of Weight Loss Affects Tirzepatide-Linked Cardiometabolic Risk Improvement
Physician's Weekly
JULY 1, 2025
TUESDAY, July 1, 2025 (HealthDay News) — For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with the degree of weight reduction, according to a study published online June 24 in the Annals of Internal Medicine. Bruno Linetzky, M.D., All rights reserved.
Let's personalize your content